食管胃静脉曲张治疗后再出血预测模型的建立与评价

艾正琳; 洪珊; 胡居龙; 李坪; 周玉玲; 梁秀霞

doi:10.3969/j.issn.1001-5256.2019.09.014

食管胃静脉曲张治疗后再出血预测模型的建立与评价

DOI: 10.3969/j.issn.1001-5256.2019.09.014

首都医科大学附属北京地坛医院消化内科

基金项目:

北京市医院管理局消化内科协调发展中心(XXZ0404)；首都特色临床应用研究(Z181100001718084)；

详细信息

中图分类号: R575.2
计量
- 文章访问数: 1202
- HTML全文浏览量: 55
- PDF下载量: 222
- 被引次数: 0
出版历程
- 收稿日期: 2019-05-15
- 出版日期: 2019-09-20

Establishment and evaluation of a predictive model for rebleeding after endoscopic treatment of esophageal and gastric varices

Department of Gastroenterology, Beijing Ditan Hospital, Capital Medical University

Research funding:

摘要

摘要: 目的建立内镜下聚桂醇联合组织胶治疗食管胃静脉曲张患者发生再出血的预测模型,并交叉验证预测模型的准确率。方法选取2014年1月-2016年12月于北京地坛医院住院治疗的180例食管胃静脉曲张出血的患者,回顾性分析其中126例患者的临床资料,包括年龄、性别、实验室指标、Child-Pugh评分、静脉曲张程度等指标。运用logistic回归分析筛选再出血的独立预测因素,并建立预测模型,选取另54例患者的临床资料进行交叉验证该预测模型的准确率。计量资料2组间比较采用独立样本t检验;计数资料2组间比较采用χ2检验。多因素分析采用logistic回归法并建立预测模型。采用受试者工作特征曲线（ROC曲线）评价预测模型,并交叉验证模型的准确率。结果 126例患者中1年内再出血发生率为46. 83%,再出血组与未出血组患者比较,PLT（t=-7. 488,P <0. 001）、国际标准化比值（t=3. 145,P=0. 002）﹑食管静脉曲张的程度（χ2=8. 841,P=0. 031）差异均有统计学意义。多因素logistic回归分析显示性别[比值比（OR）=3. 366,95%可信区间（95%...
- 食管和胃静脉曲张 /
- 出血 /
- 危险因素
Abstract: Objective To establish a predictive model for rebleeding after endoscopic injection of lauromacrogol combined with tissue adhesive in patients with esophageal and gastric varices, and to investigate its accuracy by cross validation. Methods A total of 180 patients with esophagogastric variceal bleeding who were admitted to Beijing Ditan Hospital from January 2014 to December 2016 were enrolled, and a retrospective analysis was performed for the clinical data of 126 patients, including age, sex, laboratory markers, Child-Pugh score, and degree of esophageal and gastric varices. A logistic regression analysis was used to screen out independent predictive factors for rebleeding and establish a predictive model, and the clinical data of the other 54 patients were used for cross validation of the accuracy of this model.The t-test was used for comparison of continuous data between two groups, and the chi-square test was used for comparison of categorical data between two groups. The logistic regression method was used to perform multivariate analysis and establish the predictive model. The receiver operating characteristic ( ROC) curve was used for evaluation of this model and cross validation of its accuracy. Results The 1-year rebleeding rate was 46. 83% in 126 patients, and there were significant differences between the rebleeding group and the non-rebleeding group in platelet count ( t =-7. 488, P < 0. 001) , international normalized ratio ( t = 3. 145, P = 0. 002) , and degree of esophageal varices ( χ2= 8. 841, P = 0. 031) . The multivariate logistic regression analysis showed that sex ( odds ratio [OR]= 3. 366, 95% confidence interval [CI]: 1. 015-11. 166, P = 0. 047) , platelet count ( OR = 0. 922, 95% CI: 0. 893-0. 951, P < 0. 001) , and degree of esophageal varices ( OR = 2. 422, 95% CI: 1. 179-4. 977, P = 0. 016) were independent predictive factors for rebleeding. The predictive model based on the combination of these three factors had an area under the ROC curve of 0. 876, a sensitivity of 86. 0%, and a specificity of 83. 1%.Cross validation based on the clinical data of the other 54 patients showed that this predictive model had an accuracy of 92. 6%. Conclusion Male sex and severe varices are high-risk factors for rebleeding, and platelet count is a protective factor. The predictive model based on thecombination of these three factors has a certain value in predicting rebleeding, with an accuracy of 92.6%.
- esophageal and gastric varices /
- hemorrhage /
- risk factors

HTML全文

参考文献(16)

[1] LO GH. Endoscopic treatments for portal hypertension[J].Hepatol Int, 2018, 12 (suppl 1) :91-101.

[2] HERNANDEZ-GEA V, BERBEL C, BAIGES A, et al. Acute variceal bleeding:Risk stratification and management (including TIPS) [J]. Hepatol Int, 2018, 12 (Suppl 1) :81-90.

[3] SHI KQ, LIU WY, PAN ZZ, et al. Secondary prophylaxis of variceal bleeding for cirrhotic patients:A multiple-treatments meta-analysis[J]. Eur J Clin Invest, 2013, 43 (8) :844-854.

[4] ALBILLOS A, TEJEDOR M. Secondary prophylaxis for esopgageal variceal bleeding[J]. Clin Liver Dis, 2014, 18 (2) :359-370.

[5] GARBUZENKOD V. Contemporary concepts of the medical therapy of portal hypertension under liver cirrohsis[J]. World J Gastroenterol, 2015, 21 (20) :6117-6126.

[6] TSOCHATZIS EA, BOSCH J, BURROUGHS AK. Liver cirrhosis[J]. Lancet, 2014, 383 (9930) :1749-1761.

[7] Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Endoscopy, Chinese Medical Association. Guidelines for the diagnosis and treatment of esophageal and gastric vaiceal bleeding in cirrohotic portal hypertension[J]. J Clin Hepatol, 2016, 32 (2) :203-219. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J].临床肝胆病杂志, 2016, 32 (2) :203-219.

[8] MENG Z, HU YF, LIANG DS, et al. Clinical analysis of early rebleeding after endoscopic esophageal variceal ligation in the treatment of liver cirrhosis with esophageal varices[J]. China Foreign Med Treatment, 2016, 16 (61) :61-63. (in Chinese) 蒙钊, 胡艳芳, 梁冬生, 等.肝硬化食管静脉曲张内镜下套扎治疗术后早期再出血的临床分析[J].中外医疗, 2016, 16 (61) :61-63.

[9] WANG WP, FENG J, XU L, et al. Predictive indicators of esophageal varices bleeding in hepatitis patients with liver cirrhosis[J]. Chin Gen Pract, 2015, 18 (22) :2676-2678. (in Chinese) 王万鹏, 冯静, 许蕾, 等.肝炎肝硬化患者并发食管胃底静脉曲张破裂出血的预测指标研究[J].中国全科医学, 2015, 18 (22) :2676-2678.

[10] HE Y, SU YR, HAN ZY. Current status of research on primary and secondary risk factors for esophagogastric variceal rebleeding in patients with liver cirrhosis[J]. J Clin Hepatol, 2018, 34 (7) :1555-1559. (in Chinese) 何阳, 苏亚荣, 韩子岩.肝硬化食管胃静脉曲张破裂再出血的主次危险因素研究现状[J].临床肝胆病杂志, 2018, 34 (7) :1555-1559.

[11] TERRAULT NA, LOK ASF, MCMAHON BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B:AASLD 2018 hepatitis B guidance[J]. Hepatology, 2018, 67 (4) :1560-1599.

[12] ROGALSKI P, ROGALSKA M, WROBLEWSKI E, et al. Blood platelet function abnormalities in cirrhotic patients with esophageal varices in relation to the variceal bleeding history[J].Scand J Gastroenterol, 2019, 23 (3) :1-8.

[13] GAO LL, ZHANG YJ, GAO XS, et al. Prediction of esophageal varices in patients with hepatitis C-associated liver cirrhosis by non-invasive markers[J/CD]. Chin J Liver Dis:Electr Version, 2018, 10 (3) :73-76. (in Chinese) 高丽丽, 张亦瑾, 高学松.无创性指标预测丙型肝炎肝硬化患者食管静脉曲张[J/CD].中国肝脏病杂志:电子版, 2018, 10 (3) :73-76.

[14] WANG J, ZHENG GZ. Factors related to esophageal variceal bleeding in patients with liver cirrhosis[J/CD]. Chin J Liver Dis:Electr Version, 2019, 11 (1) :42-46. (in Chinese) 王娟, 郑鸽之.肝硬化食管静脉曲张破裂出血相关因素分析[J/CD].中国肝脏病杂志:电子版, 2019, 11 (1) :42-46.

[15] DING HG, ZHANG SB, LI L, et al. Endoscopic diagnosis and treatment of esophageal and gastric varices in patients with liver cirrhosis:From guidelines to clinical practice[J]. J Clin Hepatol, 2017, 33 (3) :454-457. (in Chinese) 丁惠国, 张世斌, 李磊, 等.肝硬化食管胃底静脉曲张的内镜诊断治疗-从指南到临床实践[J].临床肝胆病杂志, 2017, 33 (3) :454-457.

[16] ZHOU HH, LI CT, SHI SL. Related factors for rebleeding within 1 year after endoscopic therapy for esophageal variceal bleeding[J]. J Clin Med, 2016, 3 (16) :3187-3188. (in Chinese) 周海华, 李池添, 石胜利.食管静脉曲张破裂出血内镜治疗后1年内再出血的相关因素分析[J].临床医药文献杂志, 2016, 3 (16) :3187-3188.

施引文献

资源附件(0)

访问统计